| P2093 | author name string | Clifford Lo | |
| | Dan Martinusen | |
| | Claudia Ho | |
| P2860 | cites work | Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy | Q24187798 |
| | Gabapentin for chronic neuropathic pain and fibromyalgia in adults | Q24194998 |
| | Cannabinoid receptor localization in brain | Q24558751 |
| | Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia | Q24607361 |
| | Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients | Q24611774 |
| | Metabolism of delta 9 -tetrahydrocannabinol by lung and liver homogenates of rats treated with methylcholanthrene | Q69955347 |
| | Ondansetron for symptomatic relief in terminal uraemia | Q72174050 |
| | A prospective evaluation of delta-9-tetrahydrocannabinol as an antiemetic in patients receiving adriamycin and cytoxan chemotherapy | Q72890308 |
| | Comparative pilot study of symptoms and quality of life in cancer patients and patients with end stage renal disease | Q79294014 |
| | The Case ∣ The smoker and the nephrologist | Q84228088 |
| | [Cannabinoid hyperemesis syndrome inducing acute prerenal failure and electrolyte disturbance] | Q84855738 |
| | Early withdrawal effects in a heavy cannabis smoker during hemodialysis | Q86099334 |
| | Cannabinoids | Q86852673 |
| | Saliva composition and upper gastrointestinal symptoms in chronic kidney disease | Q87480760 |
| | Cannabinoid receptor 2 is critical for the homing and retention of marginal zone B lineage cells and for efficient T-independent immune responses | Q24633610 |
| | The endocannabinoid system as an emerging target of pharmacotherapy | Q24648473 |
| | Adverse health effects of marijuana use | Q26861513 |
| | Inhaled Cannabis for Chronic Neuropathic Pain: A Meta-analysis of Individual Patient Data | Q28084769 |
| | International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂ | Q28298445 |
| | Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic review | Q28300877 |
| | Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide | Q28362078 |
| | Cannabinoid CB2 receptors in the enteric nervous system modulate gastrointestinal contractility in lipopolysaccharide-treated rats | Q28568772 |
| | Cannabinoids for Medical Use | Q29391539 |
| | Risks associated with the non-medicinal use of cannabis | Q30316580 |
| | Undertreatment of symptoms in patients on maintenance hemodialysis | Q30449628 |
| | Histamine induced responses are attenuated by a cannabinoid receptor agonist in human skin | Q30955557 |
| | Excerpts from the US Renal Data System 2009 Annual Data Report | Q33524945 |
| | Incidence and severity of nausea and vomiting in a group of maintenance hemodialysis patients | Q33631002 |
| | Triggering myocardial infarction by marijuana | Q33950949 |
| | Cardiovascular system effects of marijuana | Q33962206 |
| | Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the C | Q33997751 |
| | Pharmacokinetics and pharmacodynamics of cannabinoids | Q34185013 |
| | Blurred boundaries: the therapeutics and politics of medical marijuana | Q34251969 |
| | Marijuana: respiratory tract effects | Q34347280 |
| | Preliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy-induced nausea and vomiting | Q34381296 |
| | Cannabinoid hyperemesis acute renal failure: a common sequela of cannabinoid hyperemesis syndrome. | Q34397507 |
| | Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction | Q34415424 |
| | Prescribing smoked cannabis for chronic noncancer pain: preliminary recommendations | Q34453438 |
| | Effects of tobacco smoking and oral contraceptive use on theophylline disposition | Q34513078 |
| | The effects of cannabis intoxication on motor vehicle collision revisited and revised. | Q34514247 |
| | Marijuana Use and Cardiovascular Disease | Q34514546 |
| | Anorexia in end-stage renal disease: pathophysiology and treatment | Q34515499 |
| | Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome | Q34557114 |
| | Cannabis in painful HIV-associated sensory neuropathy: a randomized placebo-controlled trial | Q34575407 |
| | Dronabinol and marijuana in HIV-positive marijuana smokers. Caloric intake, mood, and sleep | Q34641364 |
| | Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010 | Q34664106 |
| | Early referral and planned initiation of dialysis: what impact on quality of life? | Q44478967 |
| | Short-term effects of cannabinoids in patients with HIV-1 infection: a randomized, placebo-controlled clinical trial | Q44579299 |
| | Enhanced biotransformation of theophylline in marihuana and tobacco smokers | Q44659080 |
| | Anandamide and its metabolites: what are their roles in the kidney? | Q45032154 |
| | Prevalence of gastrointestinal and psychosomatic symptoms among Asian patients undergoing regular hemodialysis. | Q46016382 |
| | Dronabinol and marijuana in HIV(+) marijuana smokers: acute effects on caloric intake and mood | Q46391618 |
| | Efficacy and tolerance of the cream containing structured physiological lipids with endocannabinoids in the treatment of uremic pruritus: a preliminary study | Q46832897 |
| | Blockade of cannabinoid CB1 receptors improves renal function, metabolic profile, and increased survival of obese Zucker rats | Q46991382 |
| | Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS. | Q47360477 |
| | Proximal Tubular Cannabinoid-1 Receptor Regulates Obesity-Induced CKD. | Q47874226 |
| | Cannabinoid-1 receptor deletion in podocytes mitigates both glomerular and tubular dysfunction in a mouse model of diabetic nephropathy | Q47985501 |
| | Medical Marijuana Laws Reduce Prescription Medication Use In Medicare Part D. | Q50138176 |
| | A randomized, controlled trial of early versus late initiation of dialysis. | Q51685434 |
| | Drug-drug interaction between clobazam and cannabidiol in children with refractory epilepsy. | Q53835626 |
| | Dronabinol in severe, enduring anorexia nervosa: a randomized controlled trial. | Q55057452 |
| | Comparison in the In Vitro Inhibitory Effects of Major Phytocannabinoids and Polycyclic Aromatic Hydrocarbons Contained in Marijuana Smoke on Cytochrome P450 2C9 Activity | Q56706356 |
| | Cannabis-based medicines for chronic neuropathic pain in adults | Q56815074 |
| | The role of cannabinoid signaling in acute and chronic kidney diseases | Q57173023 |
| | Cost-Effectiveness of Initiating Dialysis Early: A Randomized Controlled Trial | Q59167561 |
| | Young adult sequelae of adolescent cannabis use: an integrative analysis | Q34672949 |
| | A comparison of mainstream and sidestream marijuana and tobacco cigarette smoke produced under two machine smoking conditions | Q34722366 |
| | How cannabis causes paranoia: using the intravenous administration of ∆9-tetrahydrocannabinol (THC) to identify key cognitive mechanisms leading to paranoia | Q35096538 |
| | Chronic pain and analgesic use in CKD: implications for patient safety | Q35144435 |
| | The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis | Q35169067 |
| | Induction of proteinuria by cannabinoid receptors 1 signaling activation in CB1 transgenic mice | Q35488776 |
| | CB1 receptors mediate rimonabant-induced pruritic responses in mice: investigation of locus of action. | Q36712228 |
| | Effects of marijuana smoking on pulmonary function and respiratory complications: a systematic review | Q36734538 |
| | Metabolic effects of chronic cannabis smoking | Q37022702 |
| | Role of the endocannabinoid system in diabetes and diabetic complications | Q37085532 |
| | Poor sleep and reduced quality of life were associated with symptom distress in patients receiving maintenance hemodialysis | Q37243561 |
| | Symptom management for the adult patient dying with advanced chronic kidney disease: a review of the literature and development of evidence-based guidelines by a United Kingdom Expert Consensus Group. | Q37410714 |
| | Interpreting the clinical importance of group differences in chronic pain clinical trials: IMMPACT recommendations | Q37616606 |
| | Cannabinoid CB(2) receptors in health and disease. | Q37694610 |
| | Effects of smoking cannabis on lung function | Q37920897 |
| | Acute kidney injury associated with synthetic cannabinoid use--multiple states, 2012. | Q38081315 |
| | Acute kidney injury associated with smoking synthetic cannabinoid | Q38236657 |
| | Pruritus in Kidney Disease | Q38583951 |
| | Plasma delta-9-tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking | Q38584097 |
| | The Effects of Cannabis Among Adults With Chronic Pain and an Overview of General Harms: A Systematic Review. | Q38625602 |
| | Effects of Cannabis Use on Human Behavior, Including Cognition, Motivation, and Psychosis: A Review. | Q38722120 |
| | Cannabidiol, neuroprotection and neuropsychiatric disorders | Q38723064 |
| | Pharmacokinetic Drug Interactions with Tobacco, Cannabinoids and Smoking Cessation Products | Q38815352 |
| | Metabolism of Δ1-tetrahydrocannabinol by the isolated perfused dog lung. Comparison with in vitro liver metabolism | Q39068711 |
| | Cannabis, Cannabinoids, and Sleep: a Review of the Literature | Q39204199 |
| | Cannabinoid hyperemesis syndrome as the underlying cause of intractable nausea and vomiting | Q39268062 |
| | Factors affecting theophylline clearances: Age, tobacco, marijuana, cirrhosis, congestive heart failure, obesity, oral contraceptives, benzodiazepines, barbiturates, and ethanol | Q39288636 |
| | Comparison of ondansetron with metoclopramide in the symptomatic relief of uremia-induced nausea and vomiting | Q39410528 |
| | WHICH PATIENTS WITH CHRONIC KIDNEY DISEASE HAVE THE GREATEST SYMPTOM BURDEN? A COMPARATIVE STUDY OF ADVANCED CKD STAGE AND DIALYSIS MODALITY. | Q39952451 |
| | The cannabinoid agonist WIN 55,212-2 inhibits TNF-alpha-induced neutrophil transmigration across ECV304 cells | Q40240416 |
| | Delata-9-tetrahydrocannabinol as an antiemetic in cancer patients receiving high-dose methotrexate. A prospective, randomized evaluation | Q40627166 |
| | Cannabis use and blood pressure levels: United States National Health and Nutrition Examination Survey, 2005-2012. | Q40715158 |
| | A Phase I, open-label, randomized, crossover study in three parallel groups to evaluate the effect of Rifampicin, Ketoconazole, and Omeprazole on the pharmacokinetics of THC/CBD oromucosal spray in healthy volunteers | Q41453985 |
| | Tolerance and disposition of tetrahydrocannabinol in man | Q41549761 |
| | Human Metabolites of Cannabidiol: A Review on Their Formation, Biological Activity, and Relevance in Therapy | Q41560648 |
| | Prevalence of sleep disorders among ESRD patients | Q41749530 |
| | Cannabinoid Hyperemesis Syndrome Associated With Compulsive Showering and Acute Kidney Injury | Q41809938 |
| | Cannabinoid CB2 receptors are involved in the protection of RAW264.7 macrophages against the oxidative stress: an in vitro study | Q42324388 |
| | Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol | Q42981075 |
| | Antiemetic efficacy of smoked marijuana: subjective and behavioral effects on nausea induced by syrup of ipecac | Q43709772 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | vomiting | Q127076 |
| | chronic renal insufficiency | Q736715 |
| P304 | page(s) | 2054358119828391 | |
| P577 | publication date | 2019-01-01 | |
| P1433 | published in | Canadian journal of kidney health and disease | Q27726098 |
| P1476 | title | A Review of Cannabis in Chronic Kidney Disease Symptom Management | |
| P478 | volume | 6 | |